Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now displays a generic error HTML indicating the record is unavailable, replacing the study content and attached documents. This prevents viewing the trial details until the issue is resolved.SummaryDifference17%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label changed from v3.6.3 to v3.6.4, indicating a minor page update; no changes to study data, eligibility, or user-facing content are evident.SummaryDifference0.0%

- Check42 days agoChange DetectedThe site revision tag was updated from v3.6.2 to v3.6.3, indicating a new build of the ClinicalTrials.gov page.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This update is a metadata release tag and does not change study data or content.SummaryDifference0.1%

- Check63 days agoChange DetectedNew help/navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label has been updated. The study's recruitment status is now shown as 'No longer looking for participants,' and a new revision entry 'Revision: v3.6.0' has been introduced.SummaryDifference0.5%

- Check70 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, reflecting an update to the page's metadata.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.